Net Loss Per Share of Common Stock (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2025

Dec. 31, 2024

Net Loss Per Share of Common Stock [Abstract]

Schedule of Diluted Net Loss Per Share

The following table summarizes the number of shares of Common Stock issuable upon conversion or exercise, as applicable, of convertible securities, stock options, and warrants that were not included in the calculation of diluted net loss per share because such shares are anti-dilutive:

		For the three months ended March 31,				For the period from February 14, 2024 through March 31,				For the period from January 1, 2024 through February 14,
		2025				2024				2024
		(Successor)				(Successor)				(Predecessor)
Conversion of convertible preferred stock issued and outstanding			128,412				527				900
Conversion of convertible preferred stock underlying convertible preferred stock warrants			-				119				60
Exercise of warrants for common stock			170,274				5,080				-
Common stock underlying outstanding options (2024 Plan)			23,560				2,310				25
			322,246				8,036				985

The following table summarizes the number of shares of Common Stock issuable upon conversion or exercise, as applicable, of convertible securities, stock options, and warrants that were not included in the calculation of diluted net loss per share because such shares are anti-dilutive:

		December 31,				December 31,
		2024				2023
		(Successor)				(Predecessor)
Conversion of convertible preferred stock issued and outstanding			53,740				900
Conversion of convertible preferred stock underlying convertible preferred stock warrants			8,185				60
Exercise of public warrants and common warrants into common stock			13,193				-
Common stock underlying outstanding options (2024 Plan)			3,247				25
			78,365				985